ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 114382 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 114382; 2) Community: the network communities that were significantly associated with the response to NSC 114382; 3) Molecule: the relationships between components within communities and NSC 114382; 4) MDR: the compounds that were significantly associated with the NSC 114382.

NSC Compound Enrichment Correlation
NSC 725775 6-[(3-Thiazolylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-~ 8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride 0.0100995289754788 0.33404229
NSC 735037 Camptothecin Derivative 0.0100995289754788 0.38693222
NSC 75520 Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- (8CI 9CI) 0.0100995289754788 0.42543973
NSC 283168 Acetamide, N,N'-[(5-methoxy-2-methyl-1H-indole-4,6-diyl)bis(methylene)]bis(2-chloro- 0.0103070729572494 0.22001943
NSC 662192 Null 0.0103070729572494 0.12856285
NSC 626876 2-Cyclopenten-1-one, 5-[(dimethylamino)methyl]-2-[2-[4- (2-methylpropyl)phenyl]propyl]-, hydrochloride 0.0112651116880209 0.30853775
NSC 132230 Null 0.011265111688021 0.18655895
NSC 141545 Suavedol 0.011265111688021 0.33574302
NSC 163949 3,6-Diamino-10-methylacridinium chloride hydrochloride 0.011265111688021 -0.12202579
NSC 624873 Null 0.011265111688021 0.045306301
Total:47  Current:11    [First] [Prev] [Next] [Last]